Category Archives: Anti competition

Indian competition commission issues a path breaking order on abuse of dominant position in pharmaceuticals

Posted on April 25, 2017 by donttradeourlivesaway

Rules Roche’s practices prima facie appear to be aimed at blocking affordable biosimilar trastuzumab – a cancer drug – in India In July 2016, Mylan Pharmaceuticals and Biocon Limited approached the Competition Commission of India regarding Roche’s anti-competitive conduct to … Continue reading →

Posted in Anti competition, Biologics/Biosimilars, Campaign for Affordable Trastuzumab, Cancer | Tagged , , , , , | Leave a comment

Working to Lower Drug Costs by Challenging Questionable Patents

Posted on December 2, 2015 by donttradeourlivesaway

The New York Times, November 27, 2015. J. Kyle Bass made a fortune in the financial crisis when his hedge fund,Hayman Capital Management, bet big against subprime mortgages. Now Mr. Bass is wagering against pharmaceutical companies that he says exploit … Continue reading →

Posted in Anti competition, Evergreening, Post-grant opposition | Leave a comment

Physicians call for fairness in drug prices, availability

Posted on November 25, 2015 by donttradeourlivesaway

American Medical Association, November 17, 2015. In response to increasing drug costs impacting patient access to needed medications, physicians voted Monday at the 2015 Interim Meeting to convene a task force and launch an advocacy campaign to drive solutions and help … Continue reading →

Posted in Anti competition, Biologics/Biosimilars, Transparency | Leave a comment

Where’s India on the Trans-Pacific Partnership?

Posted on October 13, 2015 by donttradeourlivesaway

12 American, Asian and Oceanian countries have concluded their negotiations on the Trans-Pacific Partnership (TPP), an extensive free trade agreement, recently. The deal includes a number of provisions on intellectual property, that will be detrimental to access to affordable medicines. … Continue reading →

Posted in Anti competition, Asean, Data Exclusivity, Evergreening, IP Rights, Patent linkage, Patent Term Extension, Regional Comprehensive Economic Partnership, TPP, TPP, Trade Agreements, TRIPS plus, US pressure on India | Leave a comment

GlaxoSmithKline accused of market ‘abuse’

Posted on April 22, 2013 by donttradeourlivesaway

Source: BBC News 19th April,2013 GlaxoSmithKline (GSK) has been accused of market “abuse” by the consumer watchdog, the Office of Fair Trading (OFT). The OFT alleges that the pharmaceutical giant paid rivals to delay the release their own versions of GSK’s … Continue reading →

Posted in Anti competition, Generics, IP Rights | Tagged , , , | Leave a comment

ITALIAN COMPETITION AUTHORITY OPENS PROCEEDINGS AGAINST ROCHE GROUP AND NOVARTIS GROUP

Posted on April 11, 2013 by donttradeourlivesaway

Autorità Garante della Concorrenza e del Mercato DIREZIONE CENTRALE RELAZIONI ESTERNE UFFICIO STAMPA  Source: AGCM PRESS RELEASE ANTITRUST: ITALIAN COMPETITION AUTHORITY OPENS PROCEEDINGS AGAINST ROCHE GROUP AND NOVARTIS GROUP FOR AN ALLEGED CARTEL RELATED TO THE SALES IN ITALY OF THE PHARMACEUTICAL PRODUCTS … Continue reading →

Posted in Anti competition | Tagged , , , , , , | Leave a comment

Compulsory licensing of patents inquiry – draft report released

Posted on January 31, 2013 by donttradeourlivesaway

Source: Claytonutz By Richard Hoad and James Neil, 31st January,2013 The Productivity Commission’s Draft Report into the regime for the compulsory licensing of patents in Australia foreshadows significant changes to the criteria for obtaining a compulsory licence, and may also … Continue reading →

Posted in Anti competition, Compulsory Licensing | Tagged , , , , | Leave a comment

Pharma companies sued for anticompetitive scheme based on fraudulent patents

Posted on January 9, 2012 by donttradeourlivesaway

A case has been filed against the pharmaceutical companies Pfizer and Teva Pharma (generics) in the US Courts for ‘maintaining monopoly power’ and ‘for delaying entry of cheaper generic versions of anti-depressant drug Venlafaxine Hydrochloride from the US market. Venlafaxine … Continue reading →

Posted in Anti competition | Tagged | Leave a comment